	US 12,298,317 B2
	Tuberculosis detection kit
Pintong Huang, Zhejiang (CN); Yajing Liu, Zhejiang (CN); Yan Su, Zhejiang (CN); and Chao Zhang, Zhejiang (CN)
Assigned to Zhejiang SUKEAN Pharmaceutical Co., Ltd., Hangzhou (CN)
Filed by Zhejiang SUKEAN Pharmaceutical Co., Ltd., Zhejiang (CN)
Filed on May 11, 2024, as Appl. No. 18/661,576.
Application 18/661,576 is a division of application No. 18/350,764, filed on Jul. 12, 2023.
Application 18/350,764 is a continuation of application No. PCT/CN2022/136421, filed on Dec. 5, 2022.
Claims priority of application No. 202210321998.X (CN), filed on Mar. 29, 2022.
Prior Publication US 2024/0295569 A1, Sep. 5, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. G01N 33/68 (2006.01); G01N 33/53 (2006.01); G01N 33/569 (2006.01); G01N 33/92 (2006.01)

CPC G01N 33/6893 (2013.01) [G01N 33/5308 (2013.01); G01N 33/5695 (2013.01); G01N 33/92 (2013.01); G01N 2800/26 (2013.01)]

1 Claim

1. A tuberculosis detection kit, comprising detecting reagents and 17 serum metabolites of patients with tuberculosis, wherein the detecting reagent comprising an iron-particle matrix solution, and the 17 serum metabolites consisting of D-Leucic acid, Leucinic acid, L-Cystine, MG(0:0/14:0/0:0), S-Lactoylglutathione, Octacosanoic acid, Cer(d18:1/12:0), Raffinose, LysoPC(20:1(11Z)/0:0), LysoPC(22:4(7Z,10Z,13Z,16Z)/0:0), PC(18:1(9Z)e/2:0), Torvoside G, CE(16:1(9Z)), all-trans-Heptaprenyl diphosphate, PC(15:0/16:0), NADP and TG(20:0/20:0/20:1(11Z)).